✦ LIBER ✦

Prognostic factors in node negative premenopausal women treated with breast conserving therapy without adjuvant systemic therapy

✍ Scribed by Ashwini N. Budrukkar; Rajiv Sarin; Roshan F. Chinoy; Rajendra Badwe; Shyam Kishore Shrivastava; Ketayun A. Dinshaw

Book ID: 113506976
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 233 KB
Volume: 17
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2007.10.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The value of prognostic factors in selec

The value of prognostic factors in selecting node-negative breast cancer patients for adjuvant therapy

✍ Edward G. Mansour 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Prognosis of a series of 763 consecutive

Prognosis of a series of 763 consecutive node-negative invasive breast cancer patients without adjuvant therapy: Analysis of clinicopathological prognostic factor

✍ Saimura, Michiyo; Fukutomi, Takashi; Tsuda, Hitoshi; Sato, Hiroshi; Miyamoto, Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Background and Objectives: The objectives of this study were to confirm the favorable outcome of Japanese invasive breast cancer patients without lymph node metastasis, after treatment with surgery alone, and to evaluate clinicopathological prognostic factors in this population. Methods: The sub

Postmastectomy radiotherapy in premenopa

Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study

✍ Richard R Love; Nguyen Ba Duc; Nguyen Cong Binh; Peter A Mahler; Bruce R Thomads 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Prognostic significance of three novel b

Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer

✍ Jun-ichi Yamashita; Michio Ogawa; Kazuko Sakai 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 628 KB

Integration of risk factors to allow pat

Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients

✍ William C. Wood 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 645 KB

The selection of patients with axillary lymph node-negative breast cancer who should receive adjuvant therapy today is confused by an expanding arsenal of putative prognostic factors. The size of the primary tumor remains the dominant factor in sorting among this group of patients, with general agre

Adjuvant trastuzumab reduces locoregiona

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB